Fingerprint
Dive into the research topics of 'A phase ib study of onvansertib, a novel oral PLK1 inhibitor, in combination therapy for patients with relapsed or refractory acute myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically